ESTETRA SPRL has a total of 139 patent applications. It decreased the IP activity by 81.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are TRINEO BIOTECHNOLOGY CO LTD, WARNER CHILCOTT CO INC and ACIEX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 13 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | United States | 9 | |
#4 | Canada | 7 | |
#5 | Chile | 7 | |
#6 | Brazil | 6 | |
#7 | EAPO (Eurasian Patent Organization) | 6 | |
#8 | Hungary | 5 | |
#9 | Montenegro | 5 | |
#10 | Serbia | 5 | |
#11 | Singapore | 5 | |
#12 | WIPO (World Intellectual Property Organization) | 5 | |
#13 | Ecuador | 4 | |
#14 | Republic of Korea | 4 | |
#15 | Mexico | 4 | |
#16 | Slovenia | 4 | |
#17 | China | 3 | |
#18 | Colombia | 3 | |
#19 | Costa Rica | 3 | |
#20 | Israel | 3 | |
#21 | Jordan | 3 | |
#22 | Philippines | 3 | |
#23 | Taiwan | 3 | |
#24 | Uruguay | 3 | |
#25 | Argentina | 2 | |
#26 | Japan | 2 | |
#27 | Ukraine | 2 | |
#28 | Dominican Republic | 1 | |
#29 | Hong Kong | 1 | |
#30 | India | 1 | |
#31 | Morocco | 1 | |
#32 | Nicaragua | 1 | |
#33 | New Zealand | 1 | |
#34 | Peru | 1 | |
#35 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change mitigation in goods production | |
#4 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Rausin Glwadys | 55 |
#2 | Jost Maud | 53 |
#3 | Taziaux Melanie | 30 |
#4 | Mawet Marie | 30 |
#5 | Pascal Jean-Claude | 29 |
#6 | Platteeuw Johannes Jan | 21 |
#7 | Van Den Heuvel Denny Johan Marijn | 19 |
#8 | Jaspart Séverine Francine Isabelle | 15 |
#9 | Maud Jost | 14 |
#10 | Coelingh Bennink Herman Jan Tijmen | 14 |
Publication | Filing date | Title |
---|---|---|
US2020046729A1 | Methods using combined oral contraceptive compositions with reduced cardiovascular effects | |
CA3098601A1 | Treatment of advanced estrogen receptor positive breast cancer | |
TW202017573A | Compounds and their uses for alleviating menopause-associated symptoms | |
CN111683664A | Contraceptive compositions with reduced cardiovascular effects | |
JOP20200260A1 | Compounds and their uses for alleviating menopause-associated symptoms | |
MX2019001298A | Method for the management of dysmenorrhea and menstrual pain. | |
CR20190112A | Method for the management of dysmenorrhea and menstrual pain | |
KR20190076014A | How to manage menstrual cramps and menstrual cramps | |
EA035687B1 | Orodispersible dosage unit containing an estetrol component | |
CA2847813A1 | Process for the production of estetrol | |
RS55974B1 | Use of estetrol as emergency contraceptive | |
EP2714710A1 | Process for the production of estetrol intermediates |